Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

NYSE:XPOF - New York Stock Exchange, Inc. - US98422X1019 - Common Stock - Currency: USD

8.63  +0.22 (+2.62%)

After market: 8.95 +0.32 (+3.71%)

Fundamental Rating

3

Taking everything into account, XPOF scores 3 out of 10 in our fundamental rating. XPOF was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year XPOF has reported negative net income.
XPOF had a positive operating cash flow in the past year.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

With a Return On Assets value of -16.15%, XPOF is not doing good in the industry: 88.55% of the companies in the same industry are doing better.
The Return On Invested Capital of XPOF (14.51%) is better than 83.21% of its industry peers.
XPOF had an Average Return On Invested Capital over the past 3 years of 10.38%. This is significantly below the industry average of 15.91%.
The last Return On Invested Capital (14.51%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROIC 14.51%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a better Operating Margin (16.74%) than 73.28% of its industry peers.
XPOF has a Gross Margin of 75.50%. This is amongst the best in the industry. XPOF outperforms 92.37% of its industry peers.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 16.74%
PM (TTM) N/A
GM 75.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), XPOF is creating some value.
Compared to 1 year ago, XPOF has more shares outstanding
XPOF has more shares outstanding than it did 5 years ago.
XPOF has a worse debt/assets ratio than last year.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.78. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPOF (-0.78) is worse than 89.31% of its industry peers.
The Debt to FCF ratio of XPOF is 41.09, which is on the high side as it means it would take XPOF, 41.09 years of fcf income to pay off all of its debts.
XPOF has a Debt to FCF ratio (41.09) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Altman-Z -0.78
ROIC/WACC1.28
WACC11.36%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 0.81. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
XPOF has a Current ratio of 0.81. This is comparable to the rest of the industry: XPOF outperforms 41.98% of its industry peers.
XPOF has a Quick Ratio of 0.81. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of XPOF (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.75
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The earnings per share for XPOF have decreased strongly by -153.13% in the last year.
The Revenue has been growing slightly by 0.76% in the past year.
XPOF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.93% yearly.
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
Revenue 1Y (TTM)0.76%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 211.95% on average per year.
The Revenue is expected to grow by 5.88% on average over the next years.
EPS Next Y805.5%
EPS Next 2Y306.72%
EPS Next 3Y211.95%
EPS Next 5YN/A
Revenue Next Year0.45%
Revenue Next 2Y3.24%
Revenue Next 3Y5.88%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XPOF. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 5.93, the valuation of XPOF can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XPOF indicates a rather cheap valuation: XPOF is cheaper than 95.42% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, XPOF is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.93
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XPOF is valued a bit cheaper than the industry average as 61.83% of the companies are valued more expensively.
XPOF's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 47.87
EV/EBITDA 10.86
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 211.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y306.72%
EPS Next 3Y211.95%

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (8/15/2025, 8:04:00 PM)

After market: 8.95 +0.32 (+3.71%)

8.63

+0.22 (+2.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners76.52%
Inst Owner Change0.08%
Ins Owners3.65%
Ins Owner Change0.86%
Market Cap419.94M
Analysts80
Price Target14.05 (62.8%)
Short Float %11.87%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-8.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-183.83%
Min EPS beat(2)-219.74%
Max EPS beat(2)-147.92%
EPS beat(4)0
Avg EPS beat(4)-148.82%
Min EPS beat(4)-219.74%
Max EPS beat(4)-112.98%
EPS beat(8)0
Avg EPS beat(8)-93.76%
EPS beat(12)0
Avg EPS beat(12)-181.84%
EPS beat(16)0
Avg EPS beat(16)-172.7%
Revenue beat(2)2
Avg Revenue beat(2)0.29%
Min Revenue beat(2)0.01%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)4.31%
Revenue beat(16)14
Avg Revenue beat(16)6.08%
PT rev (1m)0%
PT rev (3m)-3.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.93
P/S 1.32
P/FCF 47.87
P/OCF 28.37
P/B N/A
P/tB N/A
EV/EBITDA 10.86
EPS(TTM)-0.17
EYN/A
EPS(NY)1.45
Fwd EY16.85%
FCF(TTM)0.18
FCFY2.09%
OCF(TTM)0.3
OCFY3.52%
SpS6.53
BVpS-2.23
TBVpS-7.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROCE 18.36%
ROIC 14.51%
ROICexc 15.98%
ROICexgc 148.18%
OM 16.74%
PM (TTM) N/A
GM 75.5%
FCFM 2.76%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Debt/EBITDA 5.07
Cap/Depr 37.13%
Cap/Sales 1.9%
Interest Coverage 1.29
Cash Conversion 21.32%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.75
Altman-Z -0.78
F-Score3
WACC11.36%
ROIC/WACC1.28
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%966.67%
EPS Next Y805.5%
EPS Next 2Y306.72%
EPS Next 3Y211.95%
EPS Next 5YN/A
Revenue 1Y (TTM)0.76%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-0.4%
Revenue Next Year0.45%
Revenue Next 2Y3.24%
Revenue Next 3Y5.88%
Revenue Next 5YN/A
EBIT growth 1Y-11.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year538.64%
EBIT Next 3Y104.69%
EBIT Next 5YN/A
FCF growth 1Y-79.84%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-75.39%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%